Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 4
2015 2
2016 3
2017 3
2019 6
2020 5
2021 3
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
The how's and what's of vaccine reactogenicity.
Hervé C, Laupèze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. Hervé C, et al. Among authors: tavares da silva f. NPJ Vaccines. 2019 Sep 24;4:39. doi: 10.1038/s41541-019-0132-6. eCollection 2019. NPJ Vaccines. 2019. PMID: 31583123 Free PMC article. Review.
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
Cohet C, van der Most R, Bauchau V, Bekkat-Berkani R, Doherty TM, Schuind A, Tavares Da Silva F, Rappuoli R, Garçon N, Innis BL. Cohet C, et al. Among authors: tavares da silva f. Vaccine. 2019 May 21;37(23):3006-3021. doi: 10.1016/j.vaccine.2019.04.048. Epub 2019 Apr 25. Vaccine. 2019. PMID: 31031030 Free article. Review.
Vaccine safety evaluation: Practical aspects in assessing benefits and risks.
Di Pasquale A, Bonanni P, Garçon N, Stanberry LR, El-Hodhod M, Tavares Da Silva F. Di Pasquale A, et al. Among authors: tavares da silva f. Vaccine. 2016 Dec 20;34(52):6672-6680. doi: 10.1016/j.vaccine.2016.10.039. Epub 2016 Nov 8. Vaccine. 2016. PMID: 27836435 Free article. Review.
Vaccine Adjuvants: from 1920 to 2015 and Beyond.
Di Pasquale A, Preiss S, Tavares Da Silva F, Garçon N. Di Pasquale A, et al. Among authors: tavares da silva f. Vaccines (Basel). 2015 Apr 16;3(2):320-43. doi: 10.3390/vaccines3020320. Vaccines (Basel). 2015. PMID: 26343190 Free PMC article. Review.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
de Bruyn G, Wang J, Purvis A, Ruiz MS, Adhikarla H, Alvi S, Bonaparte MI, Brune D, Bueso A, Canter RM, Ceregido MA, Deshmukh S, Diemert D, Finn A, Forrat R, Fu B, Gallais J, Griffin P, Grillet MH, Haney O, Henderson JA, Koutsoukos M, Launay O, Torres FM, Masotti R, Michael NL, Park J, Rivera-Medina DM, Romanyak N, Rook C, Schuerman L, Sher LD, Tavares-Da-Silva F, Whittington A, Chicz RM, Gurunathan S, Savarino S, Sridhar S; VAT00002 booster cohorts study team. de Bruyn G, et al. Among authors: tavares da silva f. EClinicalMedicine. 2023 Jul 22;62:102109. doi: 10.1016/j.eclinm.2023.102109. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37533419 Free PMC article.
32 results